Dr. Malhotra on Challenges with Precision Medicine in Advanced Solid Tumors
Jyoti Malhotra, MD, MPH, discusses challenges with precision medicine in advanced solid tumors.
Dr. Malhotra on the Rationale to Evaluate Racial Disparities in Lung Cancer Survivors
Jyoti Malhotra, MD, MPH, discusses the rationale to evaluate racial disparities in lung cancer survivors.
Dr. Malhotra on the Safety Profile of Plinabulin/Nivolumab/Ipilimumab in Relapsed SCLC
Jyoti Malhotra, MD, MPH, discusses the safety profile of plinabulin in combination with nivolumab and ipilimumab in relapsed/refractory small cell lung cancer.
Dr. Malhotra on Pembrolizumab During Concurrent Chemoradiation in NSCLC
Jyoti Malhotra, MD, MPH, discusses a phase I multicenter trial of PD-1 blockade with pembrolizumab with concurrent chemoradiation in patients with locally advanced, unresectable non–small cell lung cancer.
Medicaid Expansion Improves Survival in Pancreatic, Gastric Cancers, Potentially Reducing Disparities
Telephone-Based Weight Loss Program Is Effective for Breast Cancer Survivors
Pembrolizumab Plus Chemo With or Without Bevacizumab Maintains OS Benefit in Frontline Cervical Cancer
Minimally Invasive Distal Pancreatectomy Provides Effective Alternative in Resectable Pancreatic Cancer
2 Clarke Drive Cranbury, NJ 08512